Carl Zeiss enhances ophthalmic portfolio with $1B acquisition
Carl Zeiss Meditec announced today that it entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center.
Stay updated with breaking news from Markus Weber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Carl Zeiss Meditec announced today that it entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center.
/PRNewswire/ -- Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center...
/PRNewswire/ -- Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center...
Carl Zeiss Meditec AG announced today that it has entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.) from the investment firm Eurazeo SE, Paris, France. The acquisition will...
EQS-News: Carl Zeiss Meditec AG / Key word: Annual Results/Annual Report Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent 12.12.2023 /...